ConductScience.org, home

Paper29675397

Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator.

Azria D and 3 others. Front Oncol, 2018. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator. Papers, record 29675397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29675397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator.
PubMed
Journal
Front Oncol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.19
iCite
Revised in PubMed
2024-03-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Azria DDavid
2Brengues MMuriel
3Gourgou SSophie
4Bourgier CCeline

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122019144Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.Lancet2011https://conductscience.org/library/papers/22019144PubMed
227586010In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.Int J Radiat Biol2016https://conductscience.org/library/papers/27586010PubMed
316932852REporting recommendations for tumor MARKer prognostic studies (REMARK).Breast Cancer Res Treat2006https://conductscience.org/library/papers/16932852PubMed
45687489Radiation reaction in ataxia telangiectasia.Am J Dis Child1968https://conductscience.org/library/papers/5687489PubMed
526844275Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.EBioMedicine2015https://conductscience.org/library/papers/26844275PubMed
628497027Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Front Oncol2017https://conductscience.org/library/papers/28497027PubMed
727106550Correlation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy.Radiother Oncol2016https://conductscience.org/library/papers/27106550PubMed
810524426Altered apoptotic profiles in irradiated patients with increased toxicity.Int J Radiat Oncol Biol Phys1999https://conductscience.org/library/papers/10524426PubMed
922178455Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.Cancer Treat Rev2012https://conductscience.org/library/papers/22178455PubMed
1029228705YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.Oncotarget2017https://conductscience.org/library/papers/29228705PubMed
1127936985T lymphocytes to predict radiation-induced late effects in normal tissues.Expert Rev Mol Diagn2017https://conductscience.org/library/papers/27936985PubMed
1228915682Systematic review and meta-analysis of the efficacy of breast conservation therapy followed by radiotherapy in four breast cancer subtypes.Oncotarget2017https://conductscience.org/library/papers/28915682PubMed
1322385917Predictive factors for local recurrence in breast cancer.Semin Radiat Oncol2012https://conductscience.org/library/papers/22385917PubMed
1422832933Validation of a radiosensitivity molecular signature in breast cancer.Clin Cancer Res2012https://conductscience.org/library/papers/22832933PubMed
1525497158Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy.Crit Rev Oncol Hematol2015https://conductscience.org/library/papers/25497158PubMed
1611823860Gene expression profiling predicts clinical outcome of breast cancer.Nature2002https://conductscience.org/library/papers/11823860PubMed
1723580069The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial.Breast Cancer Res Treat2013https://conductscience.org/library/papers/23580069PubMed
1810799729Cellular radiosensitivity and complication risk after curative radiotherapy.Radiother Oncol2000https://conductscience.org/library/papers/10799729PubMed
1923917950Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.Ann Oncol2013https://conductscience.org/library/papers/23917950PubMed
2012829674Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis.J Clin Oncol2003https://conductscience.org/library/papers/12829674PubMed

See all 45 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
40910254BUB1B promotes homologous recombination‑mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway.Oncol Rep2025https://conductscience.org/library/papers/40910254PubMed
35108162Effects of noncoding RNAs in radiotherapy response in breast cancer: a systematic review.Cell Cycle2022https://conductscience.org/library/papers/35108162PubMed
33149754Deciphering of Key Pharmacological Pathways of Poria Cocos Intervention in Breast Cancer Based on Integrated Pharmacological Method.Evid Based Complement Alternat Med2020https://conductscience.org/library/papers/33149754PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29675397

GET https://conductscience.org/api/papers/v1/29675397/references?page=2